Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy (2014)
- Authors:
- USP affiliated authors: LACCHINI, RICCARDO - EERP ; CAVALLI, RICARDO DE CARVALHO - FMRP ; DUARTE, GERALDO - FMRP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidades: EERP; FMRP
- DOI: 10.1038/tpj.2014.26
- Subjects: INIBIDORES DE ENZIMAS; METALOPROTEINASES; POLIMORFISMO; HIPERTENSÃO NA GRAVIDEZ
- Language: Inglês
- Imprenta:
- Source:
- Título: The Pharmacogenomics Journal
- ISSN: 1470-269X
- Volume/Número/Paginação/Ano: v. 14, n. 6, p. 535-541, 2014
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão submetida (Pré-print)
- Acessar versão aberta:
-
ABNT
LUIZON, M. R. et al. Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy. The Pharmacogenomics Journal, v. 14, n. 6, p. 535-541, 2014Tradução . . Disponível em: https://doi.org/10.1038/tpj.2014.26. Acesso em: 31 mar. 2026. -
APA
Luizon, M. R., Palei, A. C. T., Sandrim, V. C., Amaral, L. M., Machado, J. S. R., Lacchini, R., et al. (2014). Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy. The Pharmacogenomics Journal, 14( 6), 535-541. doi:10.1038/tpj.2014.26 -
NLM
Luizon MR, Palei ACT, Sandrim VC, Amaral LM, Machado JSR, Lacchini R, Cavalli R de C, Duarte G, Tanus-Santos JE. Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy [Internet]. The Pharmacogenomics Journal. 2014 ; 14( 6): 535-541.[citado 2026 mar. 31 ] Available from: https://doi.org/10.1038/tpj.2014.26 -
Vancouver
Luizon MR, Palei ACT, Sandrim VC, Amaral LM, Machado JSR, Lacchini R, Cavalli R de C, Duarte G, Tanus-Santos JE. Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy [Internet]. The Pharmacogenomics Journal. 2014 ; 14( 6): 535-541.[citado 2026 mar. 31 ] Available from: https://doi.org/10.1038/tpj.2014.26 - Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy
- ENOS tagging SNP haplotypes in hypertensive disorders of pregnancy
- Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy
- Effects of NAMPT polymorphisms and haplotypes on circulating visfatin/NAMPT levels in hypertensive disorders of pregnancy
- Effects of matrix metalloproteinase (MMP)-2 polymorphisms on responsiveness to antihypertensive therapy of women with hypertensive disorders of pregnancy
- NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia
- Interethnic differences in ADMA concentrations and negative association with nitric oxide formation in preeclampsia
- Maternal iNOS genetic polymorphisms and hypertensive disorders of pregnancy
- Maternal flow-mediated dilation and nitrite concentration during third trimester of pregnancy and postpartum period
- Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
